WallStreetZenWallStreetZen

NASDAQ: XTLB
Xtl Biopharmaceuticals Ltd Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Xtl Biopharmaceuticals earnings were -$1.8M for the trailing 12 months ending Dec 31, 2023, with N/A growth year over year. For the last reported fiscal year 2023 ending Dec 31, 2023, XTLB reported annual earnings of -$1.8M, with 32.2% growth.

XTLB earnings history

Current Revenue
$0.0
Current Earnings
-$1.8M
Current Profit Margin
0%

XTLB Return on Equity

Current Company
-57.3%
Current Industry
-63.5%
Current Market
31.3%
XTLB's Return on Equity (-57.3%)... subscribe to Premium to read more.
High Return on Equity Performance

XTLB undefined

Current Company
-53.9%
Current Industry
2.9%
XTLB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when XTLB announces earnings.

XTLB undefined

Current Company
0%
Current Industry
19.5%

XTLB vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
XTLB-$1.78M-$1.78MN/A-$0.30
RNAZ-$16.19M-$16.79MN/A-$16,785,572.00
INDP-$15.02M-$15.02MN/A-$1.61
OCEA-$7.43M-$9.48MN/A-$0.34
SNGX-$8.76M-$8.27MN/A-$4.98
View Top Biotech Stocks

Xtl Biopharmaceuticals Earnings Reports & History FAQ

What was XTLB's earnings growth in the past year?

As of Xtl Biopharmaceuticals's earnings date in Invalid Date, Xtl Biopharmaceuticals's earnings has grown year over year. XTLB earnings in the past year totalled -$1.78 million.

If you're new to stock investing, here's how to buy Xtl Biopharmaceuticals stock.

Is Xtl Biopharmaceuticals profitable or losing money?

As of the last Xtl Biopharmaceuticals earnings report, Xtl Biopharmaceuticals is currently losing money. Xtl Biopharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2023 was -$1.78 million, a 32.2% increase year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.